Press release
Intas Pharmaceuticals Ltd. Chose Matrix Time-Attendance Solution to Increase Productivity of their Ahmedabad Premises
Company Profile:Intas is a leading, vertically integrated global pharmaceutical formulation development, manufacturing and marketing company headquartered in India. Intas is currently ranked 10th in the Indian Pharma Market with 2.80% market share. In the domestic market, Intas is the 4th largest corporate in Indian Chronic Pharma Market with a market share of 5.32%. Besides rapidly growing domestic prominence, Intas is also present in more than 70 countries worldwide with robust sales, marketing and distribution infrastructure in markets like North America, Europe, Central and Latin America, Africa, Australia, New Zealand, Asia-Pacific as well as CIS and MENA countries.
Challenges:
As per the guidelines provided by US-FDA, the employee needs to take certain man-hours of training as per their designation. Intas found it difficult to have a manual check over 1,000+ employees and count their training hours. They were in search of an automated solution which tracks training of every employee. Intas also wanted to integrate Matrix Time-Attendance software with their Training Module so that records of each employee are stored under a single roof. In short, they wanted to switch from manual cumbersome process to an easy on-click process.
Solution Offered:
Matrix offered its Biometric Time-Attendance solution to automate the training of Intas employees. The trainer comes to class with Matrix COSEC PATH BBU – a handheld biometric device. Employee marks a punch on Biometric device at the time of start and end. These events get stored in Matrix COSEC PATH BBU. As soon as the device is connected to server, all the stored events get auto pushed to the server. Matrix Time-Attendance software takes this events as input and gives output in the form of training man-hours of individual employees. The software seamlessly gets integrated with their training module. Thus, with Matrix Time-Attendance solution Intas was able to automate its training cell process in an easy way, while maintaining all the records digitally.
Results:
• Automated the whole training cell process whereby everything is now maintained in a single software.
• Saved employee time and increased productivity as no manual calculation of training hours for 1,000+ employees is required.
About Matrix
Established in 1991, Matrix is a leader in Telecom and Security solutions for modern businesses and enterprises. Matrix, an innovative, technology driven and customer focused organization, is committed to keep pace with the revolutions in the telecom and security industries. With more than 40% of its human resources dedicated to the development of new products, Matrix has launched cutting-edge products like IP-PBX, Universal Gateways, VoIP Gateways and Terminals, GSM Gateways, Access Control, Time-Attendance and Video Surveillance solutions. These solutions are feature-rich, reliable and conform to the international standards. Having global footprints in Asia, Europe, North America, South America and Africa through an extensive network of more than 1000 channel partners, Matrix ensures that the products serve the needs of its customers faster and longer. Matrix has gained trust and admiration of customers representing the entire spectrum of industries. Matrix has won many international awards for its innovative products.
394, GIDC Makarpura, Vadodara-390010
+91 0265 2630555
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Intas Pharmaceuticals Ltd. Chose Matrix Time-Attendance Solution to Increase Productivity of their Ahmedabad Premises here
News-ID: 837941 • Views: …
More Releases from Matrix ComSec

Secure, Scale, Succeed: 7 Video Surveillance System Features for Future-Ready Ma …
As manufacturing facilities become more automated and interconnected, the need for robust security grows more urgent. Factors like automation, supply chain complexity, and new regulatory requirements introduce security threats that many facilities aren't fully prepared for, putting people, assets, and operations at risk.
Modern industrial facilities face a diverse range of risks:
● Cargo Theft: In 2024, U.S. and Canadian businesses faced 3,625 cargo theft incidents-a 27% increase from 2023, according to CargoNet.
● Internal…

Is Your Surveillance System Truly Secure - or Just Technically Functional?
In 2017, 123 police CCTV surveillance cameras in Washington D.C. were hacked and taken offline - right before a high-profile public event. The issue wasn't the camera. It was a failure of cybersecurity compliance. (Source: BBC)
Imagine a scenario where a major supplier loses a multi-crore government contract in India because their CCTV cameras lacked a mandatory RDSO certification for use on moving coaches.
In both cases, the cameras worked. But they…

Are Smartphones the Next Surveillance Cameras?
As security threats evolve, so must the tools we use to respond to them. Fixed cameras, once the backbone of any surveillance system, are now only part of a bigger picture. Today's risks are dynamic, mobile, and unpredictable - and in many cases, they don't wait to happen in front of a network camera.
Security teams know this reality all too well. A theft in the far end of a parking…
Why STQC ER Compliance Matters for Network Camera Buyers in India
India's surveillance landscape is undergoing a significant transformation with the enforcement of new compliance regulations-STQC ER, PPO'24, and CRO'24. These frameworks, introduced by the Ministry of Electronics and Information Technology (MeitY), are designed to raise the bar for quality, cybersecurity, and trust in video surveillance products across the country.
At the center of this transformation is Essential Requirements (ER), a mandatory compliance standard aimed at ensuring hardware-level security, robust firmware protection,…
More Releases for Intas
Global Quetiapine Fumarate Market Insights, Forecast to 2027|AstraZeneca, Intas, …
Los Angeles, United States – – The report comes out as an intelligent and thorough assessment tool as well as a great resource that will help you to secure a position of strength in the global Quetiapine Fumarate market. It includes Porter’s Five Forces and PESTLE analysis to equip your business with critical information and comparative data about the Global Quetiapine Fumarate Market. We have provided a deep analysis of…
Mitomycin Market Insights by 2021| Kyowa-kirin, Intas Pharmaceuticals, Teva
QY Research has Published Latest Trending Report on Global Mitomycin Market
Los Angeles, United State, – The report titled Mitomycin Market is one of the most comprehensive and important additions to QY Research’s archive of market research studies. It offers detailed research and analysis of key aspects of the global Mitomycin market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a…
Global Dosulepin market: Current Trends, Opportunities, and Challenges|Intas, Ta …
Los Angeles, United State: The report is a compilation of comprehensive research studies on various aspects of the global Dosulepin Market. With accurate data and highly authentic information, it makes a brilliant attempt to provide a real, transparent picture of current and future situations of the global Dosulepin market. Market participants can use this powerful tool when creating effective business plans or making important changes to their strategies. The report…
Global Quetiapine Fumarate Market 2018 - AstraZeneca, Intas, TAPI, Accord, Hexal …
Apex Market Reports, recently published a detailed market research study focused on the “Quetiapine Fumarate Market” across the global, regional and country level. The report provides 360° analysis of “Quetiapine Fumarate Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Quetiapine Fumarate on…
Intas Biopharmaceuticals win GOLD award for Quality Excellence
Ahmedabad, January 27, 2010: Intas Biopharmaceuticals Limited, India’s premier biopharmaceutical organization, has received GOLD Award for Quality Excellence in the category of Formulations Unit. The award was conferred by Indian Drug Manufacturer’s Association (IDMA) on January 16, 2010 during its Annual Day Celebrations. The awards were presented by B. S. Jharwar, Chairman, National Pharmaceutical Pricing Authority (NPPA) and Devender Choudhary, Joint Secretary, Department of Pharmaceuticals. From company’s end, Mr. Hitesh…
INTAS BIOPHARMACEUTICALS ACQUIRES US–BASED BPD INC
India’s leading biopharmaceutical company, Intas Biopharmaceuticals Limited (IBPL) has acquired US-based biotechnology corporation, Biologics Process Development Incorporated (BPD Inc.), based in Poway, California. With acquisition process underway, both companies are actively pursuing plans to work closely towards fulfillment of common business objectives in the area of Contract Research and Manufacturing Services (CRAMS). With agreement in the final stages of completion, the financials has been undisclosed and will be accordingly announced…